Laboratory Products 35 SARS-CoV-2 IgG II Antibody Test to Begin Shipping to European Diagnostics Labs
Beckman Coulter, a clinical diagnostics leader, has launched its Access SARS-CoV-2 IgG II assay in countries accepting the CE Mark. The new Access SARS-CoV-2 IgG II assay quantitatively measures a patient’s level of antibodies in response to a previous SARS-CoV-2 infection. The ability to establish a quantitative baseline to evaluate an individual’s immune response to the SARS-CoV-2 virus allows clinicians to assess relative changes of an individual’s immune response to the virus over time based on a numerical value. The assay may also help researchers as they begin to understand the levels of IgG antibodies needed to be considered protective.
“Having a clearer picture of the immune response to SARS-CoV-2 plays an important role in the fight against COVID-19, especially before a vaccine is widely available,” said Shamiram R. Feinglass, MD, MPH, Chief Medical Officer at Beckman Coulter. “Determining a quantifiable baseline is a critical step towards furthering the understanding of the adaptive immune response to SARS-CoV-2 in individuals over time.”
The Access SARS-CoV-2 IgG II quantitative assay is the latest addition to Beckman Coulter’s full suite of testing solutions designed to provide valuable information to clinicians in their fight against COVID-19. Beckman Coulter also recently launched an automated SARS-CoV-2 antigen test in the US under Policy C of the FDA’s emergency use authorisation (EUA) program. While several point of care (POC) antigen tests are now available to help increase testing beyond current levels, POC tests come with workflow challenges when scaled to large patient populations. Beckman Coulter’s SARS CoV-2 Antigen test is designed to address these challenges. The organisation can deliver up to 25 million tests per month, and the assay separates sample collection and processing, enabling test providers to leverage the existing infrastructure and workflows.
Results of the new Access SARS-CoV-2 IgG II test are delivered quickly on Beckman Coulter’s award-winning immunoassay analysers, including the DxI 800 high-throughput analyser, which is capable of processing up to 200 samples per hour.
More information online:
ilmt.co/PL/DoQY 54202pr@reply-direct.com
New Interfacial Analysis Website Launched
Krüss has completely renewed the company’s website in a relaunch. Fresh content is now even more accessible whether at the office or mobile. Moreover, the focus is on a solution-oriented approach that makes navigation easier, especially for non-expert visitors.
Users are sometimes initially unaware that certain product behaviour could be related to interfacial chemistry. For example, visitors who want to remedy the lack of long-term adhesion of a coating or the formation of lumps in a dispersion are not necessarily familiar with the relevant contact angle measurement techniques. It is much more obvious to look for a solution that starts directly from the problem.
With the new website, Krüss puts this entry option in the foreground. Visitors select their material and/or their process and the website offers purposeful information from the customer-focused site: use cases, application reports, videos, products, background knowledge, and more. In addition, there is still a classic menu navigation, which quickly provides orientation with a clear structure and a variety of functions such as filters, bookmarks, or a comparison of selected products.
The new Krüss website was created in cooperation with the Hamburg agency Elbkapitäne and is available in German, English, and Chinese. More information online:
ilmt.co/PL/jzno
53952pr@reply-direct.com
Efficient Scale-Up of Novel Agrochemicals
Asynt reports how Globachem Discovery has benefited from the investment in ReactoMate reactor systems for the scale-up of novel agrochemicals.
Globachem Discovery is the UK R&D arm of Globachem, a Belgian agrochemical business. The company operates in the early phases of the R&D pipeline, developing new molecules and chemistries for the agrochemical industry. After initial biological efficacy and early toxicology validation, these novel molecules move to the Belgian R&D division for further development into highly effective and economic crop solutions.
Vicky Jackson of Globachem Discovery commented: “As Operating Officer of the
business it was important for me to identify a solution for efficient reaction scale up bridging the gap between small-scale synthesis and production of potential manufacturing routes for further product development. This capability would bring added value to the Globachem business and ensure we can efficiently deliver new products promptly. We assessed several scale-up suppliers, looking for the right equipment to offer us flexibility and the ability, to transition new compounds from early stage research at the bench to commercial manufacturing scale. We selected Asynt as our partner to build this new scale-up capability as they clearly understood our dynamic business needs, and could provide a fully integrated solution through their close working relationship with leading suppliers of stirrers and temperature control systems. Today, our chemists look to the ReactoMate systems to support a vast array of agrochemical synthesis from milligram to kilogram scale. This synthetic chemistry capability allows us to perform a wide range of chemistries such as reductions, oxidations, organometallic and classic peptide coupling reactions. The Asynt reactors allow us to work from -20°C to 180°C and perform distillations under vacuum. Together with the software which allows us to data log key information, store reaction profiles, control the temperature and the stirring speed within a reaction.”
Amanda Lyons, a synthetic chemist at Globachem Discovery added: “We have found the ReactoMate glass vessels very easy to use once bedded in. Our four systems were set up as complete reactor solutions from Asynt with Huber temperature control units. These provide highly accurate, efficient heating and cooling to our vacuum jacketed ReactoMate systems. We have found the vessel drain-off mechanism on the ReactoMate vessels easy to use and easy to dismantle for cleaning. All four reaction vessels are vacuum tight allowing us to undertake low temperature distillations. The stands supplied by Asynt are sturdy and the smaller vessels can be moved quite easily when required. Having a varied range of sizes in ReactoMate has opened up our process development capability considerably”.
More information online:
ilmt.co/PL/XR9y 53833pr@reply-direct.com
“autoclaves are our business”
New Web Site for Research Grade Laboratory Autoclaves
J J J J J
WWW.LABMATE-ONLINE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
